US Site 19 — Los Angeles, California

US Site 19 is a clinical research site located in Los Angeles, California, United States 90057.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

US Site 19 has participated in 1 clinical trials.

Therapeutic areas: Hypertriglyceridemia, Type 2 Diabetes.

Sponsors: Afimmune.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Site 19?

US Site 19 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Site 19 conducted?

US Site 19 has 1 clinical trials on record. Their work covers Hypertriglyceridemia, Type 2 Diabetes.

Is US Site 19 accredited by Crixeo Health?

US Site 19 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Site 19?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.